V2X(US:VVX)2024-05-07 14:10Financial Performance - Q1 2024 revenue increased by 7% year-over-year to $1.01 billion[8] - Q1 2024 Adjusted EBITDA was $69.1 million, representing a 6.8% margin[8] - Q1 2024 Adjusted EPS increased by 8% year-over-year to $0.90[8] - The company reaffirms its 2024 revenue guidance of $4.1 billion to $4.2 billion[31] - The company reaffirms its 2024 Adjusted EBITDA guidance of $300 million to $315 million[31] Business Highlights - Middle East growth of 22% and 7% in the Pacific year-over-year[8] - Secured awards valued at approximately $75 million to provide technology solutions for Chemical, Biological, Radiological, & Nuclear hazards[8, 12] - Awarded Air Force AFCAP task orders valued at over $140 million to continue providing support services in Romania and Jordan[8] - Won position on U.S Navy's $2 billion Global Contingency Services Multiple Award Contract III[8] Pipeline and Backlog - The company has a near-term opportunities pipeline of $25 billion[16] - The company has $16 billion NTM to be submitted[21] - The company has $9 billion bids submitted[22] - Total backlog increased by 6% year-over-year[30]